Background {#Sec1}
==========

Diabetes is one of the leading causes of death globally \[[@CR1]\]. In addition to genetic risk variants and behavioural/environmental factors, the gut microbiota is emerging as an important contributor to the pathogenesis of abnormal glucose homeostasis. The interest in the role of gut microbiota in the host's metabolic homeostasis has been sparked by the observation that germ-free mice have reduced adiposity and improved tolerance to glucose and insulin \[[@CR2]\], and are protected from diet-induced obesity and abnormal glucose homeostasis when fed a Western-style diet \[[@CR3], [@CR4]\]. The following focused studies have then indicated that the gut microbiota is crucial in the pathogenesis of human diabetes \[[@CR5]\]. The biological mechanisms for the role of the gut microbiota in diabetes has also been investigated. The gut microbiota has been shown to influence the host's capacity of energy harvest and thus impact the development of obesity that is the leading risk factor for diabetes \[[@CR5]\]. Furthermore, additional studies have demonstrated that changes in the composition and function of gut microbiota are associated with abnormal glucose homeostasis, independent of other contributing factors such as body weight \[[@CR6]\]. For example, type 2 diabetes (T2D) is associated with decreased gut butyrate-producing bacteria and/or increased gut opportunistic pathogens \[[@CR7]\], and increased lipopolysaccharide and/or branched-chain amino acid (BCAA) biosynthesis potential of gut microbiota at least partly accounts for the insulin resistance in apparently healthy individuals \[[@CR8]\]. Moreover, the high fiber diet-associated amelioration in insulin resistance and hyperglycaemia is correlated with its probiotic function, and dietary supplementation with probiotics or symbiotic improves insulin resistance in diabetic patients \[[@CR6]\]. These studies collectively indicate that the gut microbiota plays a crucial role in the pathogenesis of diabetes.

Fine particulate matter (PM~2.5~) pollution is one of the leading environmental factors affecting global public health. Numerous epidemiological studies have demonstrated that exposure to PM~2.5~ is associated with an increased risk of diabetes \[[@CR9], [@CR10]\], however, the underlying biological mechanisms have not been fully understood. Notably, recent studies showed that oral ingestion of inhalable particulate matter (PM~10~), ultrafine particulate matter (PM~0.1~), or chemicals present in ambient PM~2.5~ is sufficient to alter mouse gut microbiota \[[@CR11]--[@CR14]\] which could result in abnormal glucose metabolism. Although ingestion is not the primary route of exposure for ambient PM~2.5~ ambient particles that are inhaled and subsequently cleaned by the mucociliary escalator from the airway. Further studies are needed to determine whether inhalation exposure to ambient PM~2.5~ alters gut microbiota and subsequently causes abnormal glucose homeostasis. To this end, we exposed male C57Bl/6 J mice to concentrated ambient PM~2.5~ (CAP) or filtered air (FA) for 12 months, and analysed their glucose homeostasis and gut microbiota. The results demonstrate that chronic exposure to CAP significantly decreased the richness and composition of the faecal bacterial but not the fungal community. Furthermore, some of these alterations were significantly associated with abnormalities in glucose metabolism.

Methods {#Sec2}
=======

Animals and whole-body inhalation exposure to concentrated ambient PM~2.5~ (CAP) {#Sec3}
--------------------------------------------------------------------------------

3-week-old male C57Bl/6 J mice were purchased from the Animal Center of Shanghai Medical School, Fudan University (Shanghai, China). After 1-week acclimation, mice were subjected to exposure to FA (*n* = 10) or CAP (*n* = 10) using a versatile aerosol concentration enrichment system (VACES) that was modified for long-term whole-body exposures as previously described \[[@CR15], [@CR16]\]. The VACES was located on the campus of School of Public Health, Fudan University (130 Dong'an Road, Xuhui, Shanghai, China). The exposures were performed from March 2016 to March 2017. The exposure protocol comprised exposures for 8 h/day, 6 days/week (no exposure on Sunday). Ambient PM~2.5~ and CAP were collected weekly throughout the whole duration of exposure, and their elemental composition was determined by inductively coupled plasma mass spectroscopy (ICP-MS) for trace element analysis as previously described \[[@CR17], [@CR18]\]. During the period of exposure, mice were kept on a 12-h light/dark cycle at room temperature (20--25 °C) and 40--70% relative humidity, and received water and standard food ad lib. All procedures in the present study were approved by the institutional animal care and use committees of Fudan University, and all the animals were treated humanely and with regard for alleviation of suffering.

Intraperitoneal glucose tolerance test (IPGTT) {#Sec4}
----------------------------------------------

After 46-week-exposure to FA/CAP, mice were subjected to IPGTT on that Sunday. Before testing, mice (50 weeks old) were fasted (initiated immediately after the Saturday's exposure) for 16 h. On the day of experiments, the basal glucose level of tail vein blood was determined using an automatic glucometer (Glucotrend 2, Roche Diagnostics), and then mice were intraperitoneally injected with glucose (2 g/kg body weight). The glucose levels of the tail vein blood at 15, 30, 60, and 120 min after injection was measured as described above.

Insulin tolerance test (ITT) {#Sec5}
----------------------------

ITT was performed on mice after the 47-week-exposure to FA/CAP on that Sunday. Before testing, mice (51 weeks old) were fasted for 4 h. The basal glucose level of tail vein blood was determined using an automatic glucometer (Glucotrend 2, Roche Diagnostics) and then mice were intraperitoneally injected with insulin (0.5 U/kg body weight). The glucose levels of the tail vein blood at 15, 30, 60, and 120 min after injection was measured as described above.

Faecal sample collection {#Sec6}
------------------------

After 48-week-exposure to FA/CAP, mice (52 weeks old) were immediately transferred to empty autoclaved metabolism cage (individually housed, no bedding), and allowed to defecate normally. The 24-h faecal pellets of each mouse were collected and stored in empty autoclaved 1.5 ml Eppendorf tubes using a sterile toothpick. The faecal samples were immediately placed on dry ice and then transferred to − 80 °C freezer. Samples were stored at − 80 °C until ready to extract DNA.

DNA extraction and sequencing {#Sec7}
-----------------------------

The total genomic DNAs of the faecal samples were extracted using a MoBio PowerFecal DNA extraction kit (Qiagen) as per the manufacturer's instructions. Briefly, the samples were homogenized in a 2 ml bead beating tube containing garnet beads. The lysis of host cells and microbial cells was facilitated by both mechanical collisions between beads and chemical disruption of cell membranes, ensuring efficient extraction from even the toughest microorganisms. The total genomic DNA was captured on a silica spin column and then eluted with 50 μl of elution buffer from the column after washing with washing buffer. These genomic DNA samples were stored at − 80 °C until the preparation of sequencing libraries. To prepare the sequencing libraries, the DNA concentration and quality was determined with a NanoDrop 1000 spectrophotometer (Thermo Scientific) and by agarose gel electrophoresis (1% wt/vol agarose in tris-acetate-EDTA buffer), respectively. One sample in FA group failed in this quality control (low DNA concentration), and therefore 9 FA and 10 CAP samples were subjected to library preparation and sequencing. The bacterial 16S rRNA gene V4 region and fungal ITS1 region were amplified by PCR using primers as follows: the bacterial community \[[@CR19]\]: barcoded 515F (5′-GTG CCA GCM GCC GCG G-3′) and the reverse primer 907R (5'-CCG TCA ATT CM TTT RAG TTT-3′); the fungal community \[[@CR20]\]: ITS1F (5'-CTT GGT CAT TTA GAG GAA GTA A-3′) and ITS2R (5'-GCT GCG TTC TTC ATC GAT GC-3′). Each 20 μl PCR reaction mix included 4 μl of 5× FastPfu buffer, 2 μl of 2.5 mM dNTPs, 0.8 μl of forward primer (5 μM), 0.8 μl of reverse primer (5 μM), 0.4 μl of FastPfu polymerase, 10 ng of template DNA, and ddH~2~O was added to make up the final volume to 20 μl. Thermal cycling was performed in a 9700 PCR System (ABI, GeneAmp 9700) with the following cycling: initial denaturation at 95 °C for 5 min followed by 27 cycles of denaturation at 95 °C for 30 s, annealing at 55 °C for 30 s, extension at 72 °C for 45 s, and a final extension at 72 °C for 10 min. All PCR products were subjected to agarose gel electrophoresis (2%) followed by purification using the AXYGEN gel extraction kit (Axygen). The purified amplicons were quantified using the Quant-iT PicoGreen dsDNA Assay Kit (Thermo Fisher) and QuantiFluor™-ST Blue-florescence quantitative system (Promega). They were then sequenced using the Illumina MiSeq system (Illumina) as per the manufacturer's guidelines.

Bioinformatics analysis {#Sec8}
-----------------------

The primary sequencing data were saved in the Fastq format at SRA (Sequence Archive, <http://www.ncbi.nlm.nih.gov/Traces/sra>). All pyrosequencing reads were pre-processed based on the barcode and primer-end readers (PE readers) using Usearch software (version 7.1, [http://drive5.com/uparse/](http://drive5.com/uparse)). All reads recruited to the following analyses had the barcode, a minimal average quality score of 20, and maximally 2 mismatches within the primers. Additionally, all overlapped reads (a minimal overlap of 10 bp that had a mismatched rate of ≤0.2.) were merged. To avoid unnecessary computations, the repetitive sequences were extracted and discarded (<http://drive5.com/usearch/manual/singletons.html>). The optimized sequences were then clustered into operational taxonomics units (OTUs) using UCLUST followed by de novo OTU picking, and chimeras were removed using RDP gold database on Usearch software (version 7.1, <http://drive5.com/uparse/>). The bacterial and fungal taxonomy was assigned using Naïve Bayesian classifier in QIIME platform \[[@CR21], [@CR22]\] using SILVA database (Release 119, <http://www.arb-silva.de>) \[[@CR23]\] and Unite fungal database (Release 6, <http://unite.ut.ee/index.php>) \[[@CR24]\], respectively.

Microbial diversity and richness analysis {#Sec9}
-----------------------------------------

OTU-based alpha diversity was estimated using four matrices of Mothur (www.mothur.org /wiki/Schloss_SOP\#Alpha_diversity, version v.1.30): ACE, Chao-1, Shannon and Simpson. While ACE and Chao-1 estimators are used to reflect the total number of species in a sample, known as the richness of the community, Simpson and Shannon estimators are quantitative indicators of biodiversity in a region. The calculation of Simpson and Shannon estimators are based on different algorithms, and a larger Simpson estimator or a smaller Shannon estimator represents a lower community diversity. UniFrac distance analysis and principal co-ordinates analysis (Pcoa) using the relative abundance of OTUs were performed to estimate the beta diversity of community. In addition, linear discriminant effect size (LEfSe) analysis was used to find features differentially represented between the groups: a nonparametric factorial Kruskal-Wallis sum-rank test was used to detect significantly (*p* \< 0.05) differential taxa, and the identified taxa were further subjected to a linear discriminant analysis (LDA) to evaluate the effect size of each single differential taxon.

Mediation analysis {#Sec10}
------------------

The mediation analysis was performed to evaluate the contribution of alteration in gut microbiota to CAP exposure-induced abnormal glucose metabolism. The total effect of CAP exposure on abnormality in glucose homeostasis (*X*) was assumed to be decomposed into a direct effect (*Y*) and an indirect effect (*M*) that is mediated by alteration in gut microbiota. \[[@CR25]\] The mediation was then calculated based on two linear mixed effect (LME) models as demonstrated below \[[@CR26]\]:$$\documentclass[12pt]{minimal}
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Here *i* denotes subject (CAP exposure in the present study). *β*~0~ and $\documentclass[12pt]{minimal}
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                \begin{document}$$ {\beta}_0^{\prime } $$\end{document}$ are the intercepts for *M* and *Y*, respectively. The effect of *X* on *M* is designated as *α*, the effect of *M* on *Y* is designated as *λ*, and the direct effect of *X* on *Y* is designated as *θ*. *ε*~*i*~ and *η*~*i*~ are residuals for *M* and *Y*, respectively. The mediation analysis was conducted using R software (version 2.4.2, mediation package).

Statistical analysis {#Sec11}
--------------------

All data were presented as mean ± SEM if not specified. Statistical significances were evaluated by student's *t* test or ANOVA analysis (with Bonferroni post-test) using GraphPad Prism Software (version 5), and a *p* \< 0.05 was set as a significance. The area under curve (AUC) for each mouse's IPGTT and ITT data were calculated using GraphPad Prism Software (version 5. Y~baseline~ = 0, all peaks must go above the baseline, and ignore peaks that are less than 10% of the distance from minimum to maximum Y). The Spearman rank correlation and the Pearson correlation analyses were performed using GraphPad Prism Software (version 5).

Results {#Sec12}
=======

Chronic exposure to CAP results in glucose and insulin intolerance {#Sec13}
------------------------------------------------------------------

Figure [1a](#Fig1){ref-type="fig"} depicts the experimental scheme. The average concentration of ambient PM~2.5~ during this period was 42.1 ± 23.5 μg/m^3^, and the average PM~2.5~ concentrations in FA and CAP chambers were 12.3 ± 5.8 and 276.2 ± 170.1 μg/m^3^, respectively. As the exposure was performed for 8 h/day and 6 days/week, the 24-h average PM~2.5~exposure levels for FA- and CAP-exposed mice during this period were 33.6 and 109.0 μg/m^3^, respectively. The exposure level of the CAP group was markedly higher than the national ambient air quality standards of China (35 μg/m^3^), but was common in areas with heavy air pollution such as Beijing, China \[[@CR27]\]. Table [1](#Tab1){ref-type="table"} shows that the elemental composition of PM~2.5~ in the CAP chamber was comparable to that of ambient PM~2.5~, suggesting the technique efficiently concentrated the PM without altering its composision. The relatively high crustal elements including Si, Al, Ti, and Fe in PM~2.5~ \[[@CR28]\] reflected the undergoing major construction on this campus.Fig. 1Chronic exposure to CAP results in glucose intolerance and insulin resistance. **a** The experimental scheme. **b** the response curves of IPGTT after 12-month-exposure to FA/CAP. \**p* \< 0.05 versus FA at the same time point, repeated measures two-way ANOVA. **c** the response curves of ITT after 12-month-exposure to FA/CAP. \**p* \< 0.05 versus FA at the same time point, repeated measures two-way ANOVATable 1Ambient PM~2.5~ and CAP samples were collected weekly, and the elemental composition was determined by ICP-MSAmbientCAPμg/m^3^%μg/m^3^%Na0.12 ± 0.020.291.06 ± 0.410.38Mg0.94 ± 0.052.235.65 ± 0.832.05Al3.09 ± 0.137.3318.83 ± 2.256.82Si11.51 ± 0.4727.3271.42 ± 6.925.86P0.04 ± 0.010.090.33 ± 0.090.12S0.44 ± 0.271.056.41 ± 5.842.32Cl0.02 ± 0.030.040.74 ± 1.010.27K0.41 ± 0.060.973.16 ± 0.841.14Ca21.62 ± 0.6451.32139.19 ± 5.9650.40Ti0.94 ± 0.022.236.28 ± 0.112.27Cr0.02 ± 0.0030.060.17 ± 0.030.06Mn0.01 ± 0.010.020.21 ± 0.290.08Fe1.5 ± 0.043.5911.7 ± 2.614.24Ni0.01 ± 0.0030.030.11 ± 0.060.04Cu0.01 ± 0.0020.010.07 ± 0.060.03Zn0.06 ± 0.010.130.96 ± 0.790.35Ga0.02 ± 0.0010.040.13 ± 0.010.05As0.24 ± 0.010.571.63 ± 0.050.59Br0.003 ± 0.0050.010.18 ± 0.240.06Rb0.01 ± 0.0010.020.07 ± 0.010.02Sr0.37 ± 0.020.892.44 ± 0.070.88Y0.01 ± 0.0010.020.06 ± 0.010.02Zr0.2 ± 0.010.471.4 ± 0.050.51Nb0.01 ± 0.0010.020.05 ± 0.0010.02Sn0.005 ± 0.0040.000.01 ± 0.010.00Sb0.005 ± 0.0060.010.04 ± 0.020.01Ce0.21 ± 0.020.511.49 ± 0.030.54Pr0.03 ± 0.010.070.22 ± 0.020.08Eu0.05 ± 0.010.130.37 ± 0.060.14Gd0.01 ± 0.010.020.04 ± 0.030.01Tb0.08 ± 0.010.190.38 ± 0.180.14Er0.01 ± 0.0050.030.17 ± 0.150.06Lu0.02 ± 0.0030.050.23 ± 0.130.08W0.004 ± 0.0030.010.03 ± 0.020.01Ir0.002 ± 0.0020.000.002 ± 0.0010.00Hg0.01 ± 0.0010.020.05 ± 0.010.02Pb0.01 ± 0.0060.030.15 ± 0.10.05Bi0.002 ± 0.0010.010.03 ± 0.010.01U0.08 ± 0.020.180.73 ± 0.160.27

Chronic exposure to CAP has been shown to result in glucose intolerance and insulin resistance in various mouse models \[[@CR29], [@CR30]\]. Figure [1b](#Fig1){ref-type="fig"} and [c](#Fig1){ref-type="fig"} reveal that consistent with these previous studies, the 12-month exposure to CAP versus FA significantly impaired mouse glucose tolerance and induced a marked insulin resistance.

Chronic exposure to CAP alters the richness of gut bacterial community {#Sec14}
----------------------------------------------------------------------

Increasing evidence has indicated that the gut microbiota plays a crucial role in the homeostatic regulation of glucose metabolism \[[@CR31]\]. To investigate whether exposure to ambient PM~2.5~ causes gut dysbiosis and subsequently abnormal glucose metabolism, we collected faecal samples from the FA- or CAP-exposed mice, and characterized their bacterial and fungal communities through Illumina amplicon sequencing. The bacterial genomic DNA sequencing obtained 752,834 raw reads in total. After merging overlaps and removing repetitive reads, an average of 36,600 high quality sequences was identified and clustered into 511 OTUs. The fungal genomic DNA sequencing generated 921,548 raw reads in total. An average of 38,153 high quality sequences was identified and clustered into 669 OTUs.

The community richness and diversity estimators represent the integral level of dysbiosis of gut microbiota and predict the development of abnormal glucose metabolism \[[@CR6]\]. Figure [2a](#Fig2){ref-type="fig"} and [b](#Fig2){ref-type="fig"} demonstrate that chronic exposure to CAP significantly reduced the faecal bacterial ACE and Chao-1 estimators (the most frequently used indexes of community richness). In contrast, CAP exposure did not significantly influence the Shannon and Simpson estimators of faecal bacterial community (the indexes of the community diversity, Fig. [2c](#Fig2){ref-type="fig"} and [d](#Fig2){ref-type="fig"}). Figure [2e](#Fig2){ref-type="fig"}-[h](#Fig2){ref-type="fig"} show that CAP versus FA exposure did not significantly alter any α richness and diversity estimator of the faecal fungal community.Fig. 2Chronic exposure to CAP alters the richness but not diversity of faecal bacterial community. Male C57Bl/6 J mice were exposed to FA or CAP for 12 months and faecal samples were collected and subjected to microbiomics analysis. **a-d** the alpha diversity estimators of faecal bacterial community. **e-h** the alpha diversity estimators of faecal fungal community. *n* = 9 or 10/group. \**p* \< 0.05 versus FA, student *t* test

Chronic exposure to CAP alters the composition of gut bacterial and fungal communities {#Sec15}
--------------------------------------------------------------------------------------

To further document the effects of CAP exposure on the gut bacterial and fungal communities, hierarchical clustering analyses using taxonomical data were conducted. Figure [3a](#Fig3){ref-type="fig"} reveals three clusters by the hierarchical clustering of the bacterial community composition: one is composed of about half FA-exposed samples (FA2, FA3, FA6, FA8, FA9 and FA10); another contains about half CAP-exposed samples (CAP5, CAP7, CAP8, CAP9 and CAP10); and the third includes all the remaining samples (FA1, FA5, FA7, CAP1, CAP2, CAP3, CAP4 and CAP6). These results suggested that in spite of the marked individual variation, the clustering of samples was evident. This clustering was corroborated by principal coordinate analysis (Pcoa) using unweighted UniFrac values (Fig. [3c](#Fig3){ref-type="fig"}). In contrast, no evident clustering of samples was observed when performing hierarchical clustering and Pcoa using the fungal community composition data (Fig. [3b](#Fig3){ref-type="fig"} and [d](#Fig3){ref-type="fig"}).Fig. 3Chronic exposure to CAP alters the composition of faecal bacterial community. **a** and **b** the phyla composition of mouse faecal microbiota after 12 months exposure to FA or CAP. Hierarchical clustering analysis was conducted using taxonomical data. **c** and **d** the Pcoa using unweight UniFrac values

Figure [3a](#Fig3){ref-type="fig"} shows that the gut bacterial community of the FA- or CAP-exposed mice was primarily comprised of Bacteroidetes (60.4 ± 12.9%), Firmicutes (36.0 ± 12.7%), Deferribacteres (1.5 ± 1.7%), Tenericutes (0.9 ± 1.3%), Proteobacteria (0.7 ± 0.3%), and Cyanobacteria (0.3 ± 0.3%). The gut fungal community (Fig. [3b](#Fig3){ref-type="fig"}) comprised primarily Ascomycota (87.9 ± 8.9%), Basidiomycota (9.2 ± 9.0%), unclassified (2.7 ± 2.6%), and Zygomycota (0.2 ± 0.3%). CAP versus FA exposure did not result in any significant difference in the relative abundance of these bacterial and fungal phyla.

To document the impact of CAP exposure on the composition of gut microbiota, we performed LEfSe analyses using the relative abundance data to identify the bacterial and fungal taxa differentially represented between FA- and CAP-exposed groups. Figure [4](#Fig4){ref-type="fig"} shows that there were 24 differential bacterial taxa and 21 differential fungal taxa. Specifically, CAP exposure significantly increased the relative abundance of 9 bacterial and 17 fungal taxa, and significantly decreased the relative abundance of 15 bacterial and 4 fungal taxa.Fig. 4The differential taxa between FA- and CAP-exposed mice. **a** the cladogram of faecal bacterial community. **b** the cladogram of faecal fungal community

The association between CAP exposure-induced alterations in gut microbiota and abnormalities in glucose metabolism {#Sec16}
------------------------------------------------------------------------------------------------------------------

To test whether the alteration in gut microbiota mediates CAP exposure-induced abnormalities in glucose metabolism, we performed correlation analyses using the richness and diversity estimators of gut bacterial community and their indicators of glucose homeostasis. Figure [5a](#Fig5){ref-type="fig"} shows that while there was no significant correlation between the α diversity estimators of gut bacterial community and the fasting glucose level, the ACE and Chao-1 estimators of gut bacterial community appeared to be associated with insulin sensitivity (Fig. [5b](#Fig5){ref-type="fig"}), and all four α diversity estimators appeared to be correlated with glucose tolerance (Fig. [5c](#Fig5){ref-type="fig"}). In contrast, we did not observe any significant correlation between the richness and diversity estimators of gut fungal community and their indicators of glucose homeostasis (Fig. [5d](#Fig5){ref-type="fig"}-[f](#Fig5){ref-type="fig"}).Fig. 5The correlations between the richness and diversity of faecal microbiota and the indictors of glucose homeostasis. The Pearson's correlation analyses were performed between the fasting glucose level (**a** and **d**), the area under curve (AUC) of ITT (**b** and **e**), the AUC of IPGTT (**c** and **f**), and the alpha diversity estimators of faecal bacterial (**a-c**) or fungal (**d-f**)

To further document whether CAP exposure-induced abnormalities in glucose homeostasis can be attributable to change in any single bacterial or fungal taxon, we performed Spearman rank correlation analyses using the indicators of glucose homeostasis and the relative abundances of differential bacterial and fungal taxa. Table [2](#Tab2){ref-type="table"} reveals that there was no significant correlation between the relative abundance of differential bacterial taxa and the fasting glucose level, but the relative abundances of 14 and 20 differential bacterial taxa were significantly correlated with IPGTT AUC and ITT AUC, respectively. Of these, 2 and 9 bacterial taxa were positively correlated with IPGTT AUC and ITT AUC, respectively. In contrast, there were only 5 significant correlations between the relative abundance of differential fungal taxa and the indicators of mouse glucose homeostasis (Table [3](#Tab3){ref-type="table"}).Table 2The bacterial taxa significantly different between FA- and CAP-exposed mice (LEfSe analysis) and significantly correlated with the indicator of glucose metabolism (Spearman correlation analysis). *n* = 9 or 10/groupRankTaxonLEfSeSpearmanmean(FA)mean(CAP)*p*-valuerho*p*-valueIPGTT AUCClassEpsilonproteobacteria0.000120.000000.013−0.5370.018OrderCampylobacterales0.000120.000000.013− 0.5370.018FamilyHelicobacteraceae0.000120.000000.013−0.5370.018Peptostreptococcaceae0.000410.000000.013−0.5910.008GenusClostridium sensu stricto 10.000880.000000.013−0.5400.017Helicobacter0.000120.000000.013−0.5370.018Romboutsia0.000410.000000.013−0.5910.008Turicibacter0.000560.000000.013−0.5510.015SpeciesClostridium sensu stricto 1_uncultured bacterium0.000880.000000.013−0.5400.017Helicobacter hepaticus0.000120.000000.013−0.5370.018Romboutsia_uncultured bacterium0.000410.000000.013−0.5910.008Ruminiclostridium 5_Unclassified0.000750.001910.0170.4650.045Ruminiclostridium 5_uncultured Clostridiales bacterium0.000170.000370.0100.4580.049Turicibacter_uncultured bacterium0.000560.000000.013−0.5510.015ITT AUCClassEpsilonproteobacteria0.000120.000000.013− 0.4680.043OrderCampylobacterales0.000120.000000.013−0.4680.043Mycoplasmatales0.000000.003380.0280.4870.035FamilyHelicobacteraceae0.000120.000000.013−0.4680.043Mycoplasmataceae0.000000.003380.0280.4870.035Peptostreptococcaceae0.000410.000000.013−0.6100.006GenusClostridium sensu stricto 10.000880.000000.013−0.5720.011Helicobacter0.000120.000000.013−0.4680.043Mycoplasma0.000000.003380.0280.4870.035Romboutsia0.000410.000000.013−0.6100.006Turicibacter0.000560.000000.013−0.5590.013SpeciesAlistipes finegoldii0.009120.036250.0130.6920.001Clostridium sensu stricto 1_uncultured bacterium0.000880.000000.013−0.5720.011Helicobacter hepaticus0.000120.000000.013−0.4680.043Marvinbryantia_uncultured bacterium0.000020.000500.0350.5390.017Mycoplasma sualvi0.000000.003380.0280.4870.035Rikenella microfusus DSM 159220.000000.000670.0280.4960.031Romboutsia_uncultured bacterium0.000410.000000.013−0.6100.006Ruminiclostridium 5_Unclassified0.000750.001910.0170.6100.006Turicibacter_uncultured bacterium0.000560.000000.013−0.5590.013Table 3The fungal taxa significantly different between FA- and CAP-exposed mice (LEfSe analysis) and significantly correlated with the indicator of glucose metabolism (Spearman correlation analysis). *n* = 9 or 10/groupRankTaxonLEfSeSpearmanmean(FA)mean(CAP)*p*-valuerho*p*-valueFasting glucoseSpeciesAspergillus_flavipes0.030710.001180.0170.5780.010IPGTT AUCSpeciesAspergillus_penicillioides0.127000.235080.0010.4930.032ITT AUCGenusTalaromyces0.004570.008400.0220.5260.021SpeciesAspergillus_penicillioides0.127000.235080.0010.6670.002Talaromyces_Unclassified0.004470.008160.0170.5110.026

To statistically assess how much CAP exposure-induced abnormalities in glucose homeostasis is accounted for by changes in the gut microbiota, we performed the mediation analyses. Table [4](#Tab4){ref-type="table"} shows that the change in the Chao-1 estimator of the gut bacterial community accounted for 15% of CAP exposure-induced change in IPGTT AUC. No other significant mediation was observed.Table 4The mediation analysis. *n* = 9 or 10/groupGlucose metabolismACEChao-1ShannonSimpsonindicatorProportion mediated*p*-valueProportion mediated*p*-valueProportion mediated*p*-valueProportion mediated*p*-valueBacteriaFasting glucose−0.1180.56−0.1270.44−0.0920.68−0.0240.92IPGTT AUC0.0650.560.1540.040.1150.560.0520.48ITT AUC0.0320.880.0580.720.0230.880.0130.72FungusFasting glucose−0.290.28−0.2160.36−0.1040.56−0.2240.44IPGTT AUC0.0220.720.0360.760.0130.960.10.4ITT AUC−0.0330.76−0.0170.72−0.0780.64−0.040.8

Discussion {#Sec17}
==========

Exposure to ambient PM~2.5~ correlates to increased insulin resistance and/or impaired glucose tolerance and thus is implicated in the pathogenesis of diabetes \[[@CR10]\]. Emerging evidence has demonstrated that the gut microbiota may play an important role in the maintenance of glucose homeostasis \[[@CR31]\]. However, it remains to be determined whether PM~2.5~ exposure impacts the gut microbiota and if its adverse health effects are mediated through this alteration. In the present study, we demonstrated that chronic exposure to CAP induced marked insulin resistance and impaired glucose tolerance in C57Bl/6 J mice in association with a decrease in the richness in (ACE and Chao-1) estimators of faecal bacterial but not fungal communities, and alteration in the composition of gut microbiota. As such, the present data highlight a role of the gut microbiota in the development of adverse health effects due to exposure to ambient PM~2.5~, particularly abnormalities in glucose homeostasis.

The role of gut microbiota in the development of a multitude of complex human diseases is attracting attention in many relevant scientific communities \[[@CR31]\]. However, while exposure to ambient PM~2.5~ has been shown to correlate with the majority of these diseases, its effect on the gut microbiota remains unclear. To the best of our knowledge, this is the first study showing significant effects of inhalation exposure to CAP on the gut microbiota. Oral ingestion of inhalable particulate matter (PM~10~), ultrafine particulate matter (PM~0.1~), or chemicals present in ambient PM~2.5~ has been shown to alter mouse gut microbiota \[[@CR12]--[@CR14]\]. Although oral ingestion is not the primary route of exposure for ambient PM~2.5~ pollution, PM~2.5~ deposited in the lower airway may be cleared through the combined action of phagocytic cells (macrophages and granulocytes and the mucociliary escalator, with a marked proportion of PM~2.5~ ultimately being ingested. Therefore, these studies \[[@CR12]--[@CR14]\] not only are consistent with the present data but also provide potential mechanisms for the impact of PM~2.5~ inhalation on the gut microbiota. However, caution should be taken when interpreting these data as whether PM~2.5~ inhalation impacts the gut microbiota through the ingested PM~2.5~ remains to be determined.

The richness and diversity estimators represent the integral status of gut microbiota and appeared to be better predictors for abnormal glucose metabolism than the relative abundance of single taxon \[[@CR6]\]. While the richness reflects the number of species per sample (the more species present in a sample, the 'richer' the sample), the diversity depends not only on richness, but also on the relative abundance of the different species making up the richness of a sample. In the present study, we showed that exposure to CAP significantly decreased the richness estimators of gut bacterial community (Fig. [2a](#Fig2){ref-type="fig"} and [b](#Fig2){ref-type="fig"}), which is consistent with the absence of many bacterial taxa in the gut microbiota of CAP-exposed animals (Table [2](#Tab2){ref-type="table"}). In contrast, we did not observe any significant effect of CAP exposure on the bacterial diversity as indicated by the Shannon and Simpson estimators. This is consistent with the present data showing no significant difference in the relative abundances of bacterial phyla (Fig. [3](#Fig3){ref-type="fig"}). The lack of effect on the diversity of gut bacterial community is in direct contrast to the marked effects of ingestion of PM~10~ or PM~0.1~ on the relative abundance of phyla \[[@CR12], [@CR13]\]. This inconsistency may reflect the difference in the routes of exposure, re-emphasizing serious consideration of the route of exposure in PM~2.5~ toxicological studies.

In the present study, we corroborated the glucose intolerance and insulin resistance following chronic exposure to CAP (Fig. [1](#Fig1){ref-type="fig"}), reaffirming the glucose-metabolic effect of PM~2.5~ exposure \[[@CR32]\]. Importantly, the present study revealed an association between CAP-induced glucose intolerance and alteration in the bacterial richness (Table [4](#Tab4){ref-type="table"}), suggesting that the gut microbiota plays a role in the development of diabetes due to exposure to ambient PM~2.5~. In contrast, we did not observe any significant mediation of abnormalities in glucose homeostasis by alteration of single bacterial taxon. This is in accordance with the above-mentioned notation that the richness and diversity estimators may be better predictors for abnormal glucose metabolism than the abundance of single taxon \[[@CR6]\].

In addition to the alteration in richness of gut microbiota, the present study also calls attention to the role of some specific species in CAP exposure-induced abnormal glucose metabolism. For example, we showed that Clostridium sensu strito 1 was absent in CAP-exposed mice and meanwhile negatively correlated with mouse glucose intolerance and insulin resistance, strongly supporting its implication in CAP exposure-induced diabetes. This is perfectly consistent with its anti-diabetic effects in humans and animal models \[[@CR33]\]. The present study also showed that Helicobacter hepaticus was absent in CAP-exposed mice and negatively correlated with mouse glucose intolerance and insulin resistance. However, given that it is positively correlated with Vitamin D deficiency-induced glucose intolerance \[[@CR34]\], further study is needed to verify its role in CAP exposure-induced insulin resistance and glucose intolerance. Moreover, the present study revealed that in addition to the two species above, several other gut microbe species were significantly altered by CAP exposure and correlated with glucose intolerance and/or insulin resistance (Table [2](#Tab2){ref-type="table"}). However, their role in the host's glucose homeostasis regulation has not yet been investigated, warranting further studies to examine these correlations.

Compared to the gut bacterial community, the gut fungal community draws less attention in the diabetes area. Interestingly, the present study showed comparable numbers of bacterial and fungal differential taxa (Fig. [4](#Fig4){ref-type="fig"}). It is however noteworthy that CAP exposure decreased the abundance of most differential bacterial taxa but increased the abundance of most differential fungal taxa. Given the various examples of antagonism between bacteria and fungi \[[@CR35]\], these apparently opposite effects of CAP exposure may represent another antagonism between bacteria and fungi and thus warrant further studies to determine which the primary effect of CAP exposure is. In addition, mediation analyses showed that the decrease in the richness of gut bacterial community partly accounted for CAP exposure-induced impairment of glucose tolerance, and correlation analyses revealed much more bacterial versus fungal differential taxa that were significantly correlated with the indicators of mouse glucose metabolism (Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}).

Although the present study demonstrates a marked impact of CAP exposure on the gut microbiota and implicates it in the development of diabetes due to exposure to ambient PM~2.5~, several limitations should be noted. Firstly, we did not investigate the causality between CAP exposure-induced dysbiosis and abnormalities in glucose homeostasis. This will require using antibiotics-treated and/or germ-free mice. Secondly, we did not ascertain the time- and dose-dependency of this CAP exposure-induced dysdiosis, which are valuable for the delineation of role of gut microbiota in the development of adverse health effects due to exposure to PM~2.5~. Thirdly, while ingestion of ambient particles was shown to alter the composition and function of gut microbiota \[[@CR11]--[@CR14]\], how PM~2.5~ inhalation may impact the gut microbiota and subsequently contribute to abnormalities in glucose metabolism remains to be determined. Inflammation is widely believed to be central in the development of adverse health effects due to exposure to PM~2.5~ \[[@CR36]\]. Notably, inflammatory diseases such as multiple sclerosis and arthritis have been shown to be correlated with changes in the gut microbiota \[[@CR37]\], suggesting that inflammation may play a role in the alteration of gut microbiota due to exposure to PM~2.5~. Also, given the different feeding and pathologic patterns between humans and mice, human studies are needed to confirm the specialized role of gut microbiota in the development of abnormal glucose metabolism due to exposure to ambient PM~2.5~.

Conclusions {#Sec18}
===========

In the present study, we demonstrated that inhalation exposure to PM~2.5~ induced abnormal glucose homeostasis and change in the composition of gut microbiota. Their strong correlation suggests that the gut microbiota may be crucial for PM~2.5~ exposure-induced metabolic disorders. As such, our results suggest a novel mechanism for PM~2.5~ exposure-induced adverse health effects and thus provide potential targets for the development of effective prevention and/or treatment.
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